The association between naltrexone treatment and symptoms of depression in opioid-dependent patients

By Mysels David J.   Cheng Wendy Y.   Nunes Edward V.   Sullivan Maria A.  

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 1, 2011-01 ,pp. : 22-26

Informa Healthcare

Access to resources Recommend Favorite

A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients

By Kim Sung-Gon  

Psychopharmacology, Vol. 201, Iss. 4, 2009-01 ,pp. : 611-618

Springer Publishing Company

Access to resources Recommend Favorite

Sustained-release naltrexone: novel treatment for opioid dependence

By Comer Sandra D   Sullivan Maria A   Hulse Gary K  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1285-1294

Informa Healthcare

Access to resources Recommend Favorite

Management of an opioid-impaired anaesthetist by implantable naltrexone

By Hulse Gary   O'Neil George   Arnold-Reed Diane  

Journal of Substance Use, Vol. 9, Iss. 2, 2004-04 ,pp. : 86-90

Radcliffe Press

Access to resources Recommend Favorite

The Combination Very Low-Dose Naltrexone–Clonidine in the Management of Opioid Withdrawal

By Mannelli Paolo   Peindl Kathleen   Wu Li-Tzy   Patkar Ashwin A.   Gorelick David A.  

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 3, 2012-05 ,pp. : 200-205

Informa Healthcare

Access to resources Recommend Favorite